Jul 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2018 Jun 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.18 985 mln 4.70
(+19.5 pct) (-22.2 pct) (+7.1 pct)
Operating 198 mln 79 mln 400 mln
(+149.6 pct) (-56.3 pct) (-12.4 pct)
Recurring 201 mln 93 mln 400 mln
(+115.7 pct) (-42.0 pct) (-16.2 pct)
Net 137 mln 58 mln 280 mln
(+134.5 pct) (-31.1 pct) (+0.7 pct)
EPS 32.98 yen 14.07 yen 66.98 yen
Ann Div 12.50 yen 12.50 yen
-Q2 div NIL NIL
-Q4 div 12.50 yen 12.50 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T